- Prospectus filed pursuant to Rule 424(b)(3) (424B3)
December 27 2011 - 10:52AM
Edgar (US Regulatory)
December 21, 2011
SECURITIES & EXCHANGE COMMISSION
450 Fifth Street, NW
Washington, DC 20549
Attn.: Document Control
RE: American Depositary Receipts
representing twenty deposited
shares of
Novogen Limited
(Form F6, Registration No.
333128681)
Ladies and Gentlemen:
Pursuant to Rule 424(b)(3) under the
Securities Act of 1933, as amended, on
behalf of The Bank of New York Mellon, as
Depositary for securities against which
American Depositary Receipts are to be
issued, we attach a copy of the new
prospectus (Prospectus) reflecting the change
in number of ordinary shares represented by
one American Depositary Share (the Ratio).
As required by Rule 424(e), the upper right
hand corner of the Prospectus cover page has
a reference to Rule 424(b)(3) and to the file
number of the registration statement to which
the Prospectus relates.
Pursuant to Section III B of the General
Instructions to the Form F6 Registration
Statement, the Prospectus consists of the
ADR certificate with the revised ratio for
Novogen Limited.
The Prospectus has been revised to reflect the
new ratio, and has been overstamped with:
Effective January 3, 2012 the ratio is
changed to One (1) American Depositary
Share represents Twenty five (25)
deposited Shares.
Please contact me with any questions or
comments at 212 8152281
Rajan Balsara
Vice President
The Bank of New York Mellon ADR
Division
Encl.
CC: Paul Dudek, Esq. (Office of International
Corporate Finance)
101 Barclay Street, 22nd Floor West, New York, NY 10286
Kazia Therapeutics (NASDAQ:KZIA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Kazia Therapeutics (NASDAQ:KZIA)
Historical Stock Chart
From Jul 2023 to Jul 2024